Acceleron Pharma Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €79.85M +25.0% -€143.29M +33.0% -179.4% -0.11 pp -€108.85M +39.3% -136.3% -0.14 pp
    €63.86M +428.9% -€107.76M +5.0% -168.7% +6.8 pp -€78.12M -1.7% -122.3% +5.4 pp
    €12.07M +3.8% -€102.59M +9.6% -849.6% -0.45 pp -€79.50M +27.3% -658.4% -1.2 pp
    €11.63M -51.5% -€93.60M +90.2% -804.5% -6.0 pp -€62.43M +75.1% -536.6% -3.9 pp
    €23.97M +53.5% -€49.21M -10.8% -205.3% +1.5 pp -€35.66M -4.5% -148.8% +0.90 pp
    €15.62M +23.7% -€55.14M +24.6% -353.1% -0.027 pp -€37.33M -17.9% -239.0% +1.2 pp
    €12.63M -74.4% -€44.24M +134.1% -350.3% -3.1 pp -€45.49M +172.5% -360.2% -3.3 pp
    €49.39M +275.2% -€18.90M -32.8% -38.3% +1.8 pp -€16.69M -49.7% -33.8% +2.2 pp
    €13.16M -81.1% -€28.12M -189.8% -213.6% -2.6 pp -€33.18M -523.2% -252.0% -2.6 pp
    €69.83M €31.30M 44.8% €7.84M 11.2%

    Notifications